Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer

OncoImmunology

Volumn 1, Issue 5, 2012, Pages 789-790

  Martinet, Ludovic ^a,b   Garrido, Ignacio ^a,b,c   Girard, Jean Philippe ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Blood vessel; Breast cancer; CD8 T cell; Lymphocyte infiltration; Prognosis

Indexed keywords

ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER PROGNOSIS; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE COURSE; ENDOTHELIUM CELL; HIGH ENDOTHELIAL VENULE; HUMAN; IMMUNOCOMPETENT CELL; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MEMORY T LYMPHOCYTE; PREDICTION; PRIORITY JOURNAL; SOLID TUMOR; TH17 CELL; TUMOR MICROENVIRONMENT; VENULE;

EID: 84881439391     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19787     Document Type: Article

References (9)

1. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
2. Denkert C, Loibl S, Noske A, Roller M, Müller BM, Komor M, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010; 28:105-13; PMID:19917869; http://dx.doi.org/10.1200/JCO.2009.23.7370
3. Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995; 16:449-57;PMID:7546210; http://dx.doi.org/10.1016/0167-5699(95)80023-9
4. Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011; 71:5678-87; PMID: 21846823; http://dx.doi.org/10.1158/0008-5472.CAN-11-0431
5. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6:715-27; PMID: 16977338; http://dx.doi.org/10.1038/nri1936
6. Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, et al. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 2008; 14:28-36; PMID:18157142; http://dx.doi.org/10.1038/nm1699
7. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003; 3: 867-78; PMID:14668803; http://dx.doi.org/10.1038/nri1222
8. Schrama D, thor Straten P, Fischer WH, McLellan AD, Bröcker EB, Reisfeld RA, et al. Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001; 14:111-21; PMID:11239444; http://dx.doi.org/10.1016/S1074-7613(01)00094-2
9. Moussion C, Girard JP. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011; 479:542-6; PMID:22080953; http://dx.doi.org/10.1038/nature10540